MAB 806 enhances the efficacy of ionizing radiation in glioma xenografts expressing the DE2-7 epidermal growth factor receptor

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 2, 2010, Pages 572-578

  Johns, Terrance G ^a   McKay, Michael J ^b   Cvrljevic, Anna N ^a   Gan, Hui K ^a   Taylor, Caitlin ^b   Xu, Huiling ^b   Smyth, Fiona E ^a   Scott, Andrew M ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

de2 7 EGFR; Glioma; mAb 806; Radiation therapy; Radiosensitization

Indexed keywords

DE2-7 EGFR; GLIOMA; MAB 806; RADIATION THERAPY; RADIO-SENSITIZATION;

AMINO ACIDS; ANTIBODIES; BEARINGS (STRUCTURAL); IONIZING RADIATION; PEPTIDES; PHOSPHATASES; PHOSPHORYLATION; RADIATION SHIELDING; RADIOACTIVITY; RADIOTHERAPY;

TUMORS;

DNA DEPENDENT PROTEIN KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; MONOCLONAL ANTIBODY 806; PROTEIN KINASE B; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR VIII; MONOCLONAL ANTIBODY; RADIOSENSITIZING AGENT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; GLIOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IONIZING RADIATION; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RADIOSENSITIZATION; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; BRAIN NEOPLASMS; DRUG SCREENING; GENE DELETION; GENETICS; METABOLISM; MULTIMODALITY CANCER THERAPY; NEOVASCULARIZATION, PATHOLOGIC; NUDE MOUSE; PATHOLOGY; PROCEDURES; TUMOR VOLUME; VASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DNA-ACTIVATED PROTEIN KINASE; FEMALE; GENE DELETION; GLIOMA; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; RADIATION-SENSITIZING AGENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79551600490     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.03.027     Document Type: Article

References (49)

1. D.A. Reardon, J.N. Rich, and H.S. Friedman DD. Recent advances in the treatment of malignant astrocytoma J Clin Oncol 24 2006 1253 1265
2. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 comment 1036-1038
3. J.S. Smith, I. Tachibana, and S.M. Passe PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme J Natl Cancer Inst 93 2001 1246 1256
4. A.B. Heimberger, R. Hlatky, and D. Suki Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients Clin Cancer Res 11 2005 1462 1466
5. N. Shinojima, K. Tada, and S. Shiraishi Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme Cancer Res 63 2003 6962 6970
6. A.J. Ekstrand, C.D. James, and W.K. Cavenee Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo Cancer Res 51 1991 2164 2172
7. N. Sugawa, A.J. Ekstrand, and C.D. James Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas Proc Natl Acad Sci U S A 87 1990 8602 8606
8. L. Frederick, X.Y. Wang, and G. Eley Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas Cancer Res 60 2000 1383 1387
9. A.J. Ekstrand, N. Sugawa, and C.D. James Amplified and rearranged epidermal growth factor receptor genes in human glioblastomas reveal deletions of sequences encoding portions of the N- and/or C-terminal tails Proc Natl Acad Sci U S A 89 1992 4309 4313
10. P.A. Humphrey, A.J. Wong, and B. Vogelstein Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts Cancer Res 48 1988 2231 2238
11. H. Yamazaki, Y. Ohba, and N. Tamaoki A deletion mutation within the ligand binding domain is responsible for activation of epidermal growth factor receptor gene in human brain tumors Jpn J Cancer Res 81 1990 773 779
12. S. Saikali, T. Avril, and B. Collet Expression of nine tumour antigens in a series of human glioblastoma multiforme: Interest of EGFRvIII, IL-13Ralpha2, gp100 and TRP-2 for immunotherapy J Neurooncol 81 2007 139 148
13. I.K. Mellinghoff, M.Y. Wang, and I. Vivanco Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors N Engl J Med 353 2005 2012 2024
14. D.K. Moscatello, M. Holgado-Madruga, and A.K. Godwin Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors Cancer Res 55 1995 5536 5539
15. I.E. Garcia de Palazzo, G.P. Adams, and P. Sundareshan Expression of mutated epidermal growth factor receptor by non-small cell lung carcinomas Cancer Res 53 1993 3217 3220
16. H.S. Huang, M. Nagane, and C.K. Klingbeil The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling J Biol Chem 272 1997 2927 2935
17. G. Lammering, T.H. Hewit, and K. Valerie EGFRvIII-mediated radioresistance through a strong cytoprotective response Oncogene 22 2003 5545 5553
18. B. Li, M. Yuan, and I.A. Kim Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin Oncogene 23 2004 4594 4602
19. G. Lammering, T.H. Hewit, and M. Holmes Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity Clin Cancer Res 10 2004 6732 6743
20. A. Abdollahi, D.W. Griggs, and H. Zieher Inhibition of alpha(v)beta3 integrin survival signaling enhances antiangiogenic and antitumor effects of radiotherapy Clin Cancer Res 11 2005 6270 6279
21. P.E. Huber, M. Bischof, and J. Jenne Trimodal cancer treatment: Beneficial effects of combined antiangiogenesis, radiation, and chemotherapy Cancer Res 65 2005 3643 3655
22. A. Abdollahi, K.E. Lipson, and X. Han SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro Cancer Res 63 2003 3755 3763
23. H.J. Mauceri, N.N. Hanna, and M.A. Beckett Combined effects of angiostatin and ionizing radiation in antitumour therapy Nature 394 1998 287 291
24. A.B. Heimberger, C.A. Learn, and G.E. Archer Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (Iressa) Clini Cancer Res 8 2002 3496 3502
25. C.A. Learn, T.L. Hartzell, and C.J. Wikstrand Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme Clin Cancer Res 10 2004 3216 3224
26. D. Haas-Kogan, M. Prados, and T. Tihan Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib J Natl Cancer Inst 97 2005 880 887
27. A.A. Jungbluth, E. Stockert, and H.J. Huang A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor Proc Natl Acad Sci U S A 100 2003 639 644
28. R.B. Luwor, T.G. Johns, and C. Murone Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR Cancer Res 61 2001 5355 5361
29. K. Mishima, T.G. Johns, and R.B. Luwor Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor Cancer Res 61 2001 5349 5354 (Pubitemid 32694908)
30. T.G. Johns, R.B. Luwor, and C. Murone Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478 Proc Natl Acad Sci U S A 100 2003 15871 15876
31. A.M. Scott, F.-T. Lee, and N. Tebbutt A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors 10.1073/pnas.0611693104 Proc Natl Acad Sci U S A 104 2007 4071 4076
32. R.B. Lichtner, M. Wiedemuth, and A. Kittmann Ligand-induced activation of epidermal growth factor receptor in intact rat mammary adenocarcinoma cells without detectable receptor phosphorylation J Biol Chem 267 1992 11872 11880
33. R.M. Perera, Y. Narita, and F.B. Furnari Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity Clin Cancer Res 11 2005 6390 6399
34. T.G. Johns, R.M. Perera, and S.C. Vernes The efficacy of epidermal growth factor receptor-specific antibodies against glioma xenografts is influenced by receptor levels, activation status, and heterodimerization Clin Cancer Res 13 2007 1911 1925
35. K. Mishima, T.G. Johns, and R.B. Luwor Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor Cancer Res 61 2001 5349 5354 (Pubitemid 32694908)
36. C.I. Sartor Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors Nat Clin Pract Oncol 1 2004 80 87
37. J. Mendelsohn, and J. Baselga The EGF receptor family as targets for cancer therapy Oncogene 19 2000 6550 6565
38. S.R. Datta, A. Brunet, and M.E. Greenberg Cellular survival: A play in three Akts Genes Dev 13 1999 2905 2927
39. J. Feng, J. Park, and P. Cron Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase J Biol Chem 279 2004 41189 41196
40. M. French, M. Andjelkovic, and E. Ingley High affinity binding of inositol phosphates and phosphoinositides to the pleckstrin homology domain of RAC/protein kinase b and their influence on kinase activity J Biol Chem 272 1997 8474 8481
41. S.M. Huang, and P.M. Harari Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis Clin Cancer Res 6 2000 2166 2174
42. D. Bandyopadhyay, M. Mandal, and L. Adam Physical interaction between epidermal growth factor receptor and DNA-dependent protein kinase in mammalian cells J Biol Chem 273 1998 1568 1573
43. S.A. Weppler, Y. Li, and L. Dubois Expression of EGFR variant vIII promotes both radiation resistance and hypoxia tolerance Radiother Oncol 83 2007 333 339
44. B. Solomon, J. Hagekyriakou, and M.K. Trivett EGFR blockade with ZD1839 ("Iressa") potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma: Epidermal growth factor receptor Int J Radiat Oncol Biol Physics 55 2003 713 723 (Pubitemid 36172491)
45. S.M. Huang, J. Li, and E.A. Armstrong Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa) Cancer Res 62 2002 4300 4306
46. D. Raben, C. Bianco, and V. Damiano Antitumor activity of ZD6126, a novel vascular-targeting agent, is enhanced when combined with ZD1839, an epidermal growth factor receptor tyrosine kinase inhibitor, and potentiates the effects of radiation in a human non-small cell lung cancer xenograft model Mol Cancer Ther 3 2004 977 983
47. M.W. Pedersen, N. Pedersen, and L. Damstrup Analysis of the epidermal growth factor receptor specific transcriptome: Effect of receptor expression level and an activating mutation J Cell Biochem 96 2005 412 427
48. T.G. Johns, E. Stockert, and G. Ritter Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene Int J Cancer 98 2002 398 408
49. C. Cao, J.M. Albert, and L. Geng Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer Cancer Res 66 2006 11409 11415